Antimikrobiyal Direnç ve Kontrolü

Saltoğlu N. Antibiyotiklere direnç problemi ve etkileri. Klinik Derg., 2005;18(1):178-80.

Saltoğlu N. Antibiyotiklerin uygulama yolları, dozları, besin ve ilaçlarla etkileşimleri. ÇÜ Tıp Fak AŞİV Derg. 2000; 9:336-65.

Paradisi F, Corti G, Sboragli S, Benedetti M. Effect of antibiotic treatment on resistance. Semin Respir Infect. 2002;17(3):240-5.

Colgar R, Powers JH. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance. Am Fam Physician. 2001:64(6):999-1004.

MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):628-56.

Moellering RC, Eliopoulos GM. Principles of anti- infective therapy. In: Mandell GL, Bennett JE Dolin R, eds Principles and Practice of Infectious Disease 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005;16:242-52.

Lacoviello VT, Zinner SH. Principles of anti-infective therapy. In: Cohen J, Powderly WG, eds. Infectious Diseases 2nded. Spain: Mosby, Elsevier; 2004.p.1705-11.

Thompson RI, Wright AJ. General principles of antimicrobial therapy. Mayo Clinic Proc. 1998; 73(10): 995-1006.

Polk R. optimal use of modern: Emerging trends. Clin Infect Dis. 1999; 29(2):264-74.

Harbottle H, Thakur S, Zhao S, White DG. genetics of antimicrobial resistance. Anim Biotechnol. 2006;17(2): 111-24.

Davies J, Davies D, Origins and evolution of antimicrobial resistance. Microbiol Mol Biol Rev. 2010; 74(39: 417-33.

Woodford N, Ellington MJ. The emergence of antimicrobial resistance by mutation. Clin Microbiol Infect. 2007;13 (1):5-18.

Opal SM, Pop-Vicas A. Molecular mechanisms of antimicrobial resistance in bacteria. In Mandell GL, Bennett JE, Dolin R, eds. Mandelli Douglas & Bennett’s Principles and Practice of Infectious Diseases. 7thed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010. P. 279-95.

Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol. 2010; 37(3):3547-63.

Turnidge J, Collingnon P. Resistance to fusidic acid. Int J. Antimicrob Agents. 1999;12 Suppl 2: 535-44.

Eraksoy H. Antimicrobial resistance and resistance mechanisms. J Inf Dis-Special Topics. 2011;4(1):1-14.

Wright GD. Molecular mechanisms of Antibiotic resistance. Chem Commun (Lamb). 2011;47(14):4055-61.

Chen LF, Chopra T, Kaye KS. Pathogens resistant to antimicrobial agents. Med Clin North Am. 2011;95(4) 647-76.

Fraimow HS, Tsigrelis C. Antibiotic resistance in the intensive care unit; mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011; 27(1):163-205.

Delcour AH. Outer membrane permeability and Antibiotic resistance. Biochim Biophys Acta. 2009; 1794151:808-16.

Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria an update. Drugs. 2009;69(12):1555-623.

Lambert PA. Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev. 2005:57(10):1471-85.

Azap KÖ. Impact of Agricultural Antimicrobial Use on Antimicrobial Resistance. J Inf Dis-Special Topics. 2011; 4 (1): 78-81.

Hamer DH, Gill JC. From the farm to the kitchen table: The negative impact of antimicrobial use in animals on humans. Nutr Rev. 2002;60:261-5.

Werner G, Klare I, Witte W. Molecular analysis of streptogramin resistance in enterococci. Int J Med Microbiol. 2002;292:81-95.

Akalın H. Yoğun bakım ünitesinde antibiyotik direncini azaltma ve önleme. ANKEM Derg. 2009; 23(Ek 2): 157-61.

Paterson DL. “Collateral Damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38 suppl 4:9341-45.

Schiaes DM, Gerding DN, John JF, Craig W, Bornstein DL, Duncan RA, et al. Society for healthcare epidemiology of America and infectious Diseases Society of America Joint Committee on the prevention of Antibiotic resistance: Guidelines for the prevention of Antibiotic resistance in hospitals. Clin Infect Dis. 1997; 25(31):584-99.

Goessens H, Ferech M, Stichele RV, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005: 365(9459):579-87.

Kollef MH. Is there a role Antibiotic cycling in the in intensive care unit. Crit Care Med. 2001; 29(Suppl4):135-42.

Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med. 2005; 33(8):1845-53.

Yates RR. Nev intervention strategies for reducing Antibiotic resistance. Chest. 1999:11513Suppl: 245-275.

Giamarellou IT, Antonizdou A. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital. In: Symposium on antibiotic resistance Origins, evolution, selection and spread. Ciba Foundation Symp, London 1997. 207: 76-80.

White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997; 25(2) 230.

Özkurt Z, Erol S, Kadanalı A, Ertek M, Özdek K, Taşyaran MA. Change, is antibiotic use cost and consumption after an antibiotic restriction policy applied by infectious diseases specialists. Jpn J Infect Dis. 2005; 58(6): 338-43.

Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, Buke c, Ulusoy S. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect. 2007; 55(1) 41-8.

Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther. 2008; 6(4):523-39.

Leanne B. Gasink Md, Lautenbach E, Prevention and Treatment of Health Care- Acquired İnfections. Med Clin N Am. 2008:92:295-313.

Patterson JE, Multidrug-resistant gram-negative pathogens: multiple approaches and measures for prevention. Infect Control Hosp Epidemiol. 2006;27:889-92.

Talboot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Barlett JG. Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin infect Dis. 2006;42:657-68.

Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249-56.

Loupland KB, Zygun DA, Doig CJ, et al. One year mortability of blood stream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med. 2005;31-213-19.

Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North. 2009; 23:703-25.

Anonim, 2019. World Health Organization, WHO Global Strategy for containment of antibiotic resistance Who/CDS/CSR/DRS/2001.2.

Ho PL, Cheng JC, Ching PT, et al. Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement. Hong Kong Med J. 2006;12-141-48.

Agalar C. Antibiyotik seçimi için ek bileşenler. Ed. Prof Dr. Dilek Arman, Prof. Dr. Oğuz Güç. Birinci Basamakta enfeksiyon Hastalıklarının Tedavisi: Akılcı Farmakoterapi, Bilimsel Tıp Yayınevi, Ankara 2008;41-9.

Saltoğlu N. Antibiyotiklere direnç problemi ve etkileri. Klinik Derg., 2005;18(1):178-80.

Saltoğlu N. Antibiyotiklerin uygulama yolları, dozları, besin ve ilaçlarla etkileşimleri. ÇÜ Tıp Fak AŞİV Derg. 2000; 9:336-65.

Paradisi F, Corti G, Sboragli S, Benedetti M. Effect of antibiotic treatment on resistance. Semin Respir Infect. 2002;17(3):240-5.

Colgar R, Powers JH. Appropriate antimicrobial prescribing: approaches that limit antibiotic resistance. Am Fam Physician. 2001:64(6):999-1004.

MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):628-56.

Moellering RC, Eliopoulos GM. Principles of anti- infective therapy. In: Mandell GL, Bennett JE Dolin R, eds Principles and Practice of Infectious Disease 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2005;16:242-52.

Lacoviello VT, Zinner SH. Principles of anti-infective therapy. In: Cohen J, Powderly WG, eds. Infectious Diseases 2nded. Spain: Mosby, Elsevier; 2004.p.1705-11.

Thompson RI, Wright AJ. General principles of antimicrobial therapy. Mayo Clinic Proc. 1998; 73(10): 995-1006.

Polk R. optimal use of modern: Emerging trends. Clin Infect Dis. 1999; 29(2):264-74.

Harbottle H, Thakur S, Zhao S, White DG. genetics of antimicrobial resistance. Anim Biotechnol. 2006;17(2): 111-24.

Davies J, Davies D, Origins and evolution of antimicrobial resistance. Microbiol Mol Biol Rev. 2010; 74(39: 417-33.

Woodford N, Ellington MJ. The emergence of antimicrobial resistance by mutation. Clin Microbiol Infect. 2007;13 (1):5-18.

Opal SM, Pop-Vicas A. Molecular mechanisms of antimicrobial resistance in bacteria. In Mandell GL, Bennett JE, Dolin R, eds. Mandelli Douglas & Bennett’s Principles and Practice of Infectious Diseases. 7thed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010. P. 279-95.

Patel SJ, Saiman L. Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship. Clin Perinatol. 2010; 37(3):3547-63.

Turnidge J, Collingnon P. Resistance to fusidic acid. Int J. Antimicrob Agents. 1999;12 Suppl 2: 535-44.

Eraksoy H. Antimicrobial resistance and resistance mechanisms. J Inf Dis-Special Topics. 2011;4(1):1-14.

Wright GD. Molecular mechanisms of Antibiotic resistance. Chem Commun (Lamb). 2011;47(14):4055-61.

Chen LF, Chopra T, Kaye KS. Pathogens resistant to antimicrobial agents. Med Clin North Am. 2011;95(4) 647-76.

Fraimow HS, Tsigrelis C. Antibiotic resistance in the intensive care unit; mechanisms, epidemiology, and management of specific resistant pathogens. Crit Care Clin. 2011; 27(1):163-205.

Delcour AH. Outer membrane permeability and Antibiotic resistance. Biochim Biophys Acta. 2009; 1794151:808-16.

Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria an update. Drugs. 2009;69(12):1555-623.

Lambert PA. Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev. 2005:57(10):1471-85.

Azap KÖ. Impact of Agricultural Antimicrobial Use on Antimicrobial Resistance. J Inf Dis-Special Topics. 2011; 4 (1): 78-81.

Hamer DH, Gill JC. From the farm to the kitchen table: The negative impact of antimicrobial use in animals on humans. Nutr Rev. 2002;60:261-5.

Werner G, Klare I, Witte W. Molecular analysis of streptogramin resistance in enterococci. Int J Med Microbiol. 2002;292:81-95.

Akalın H. Yoğun bakım ünitesinde antibiyotik direncini azaltma ve önleme. ANKEM Derg. 2009; 23(Ek 2): 157-61.

Paterson DL. “Collateral Damage” from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis. 2004;38 suppl 4:9341-45.

Schiaes DM, Gerding DN, John JF, Craig W, Bornstein DL, Duncan RA, et al. Society for healthcare epidemiology of America and infectious Diseases Society of America Joint Committee on the prevention of Antibiotic resistance: Guidelines for the prevention of Antibiotic resistance in hospitals. Clin Infect Dis. 1997; 25(31):584-99.

Goessens H, Ferech M, Stichele RV, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005: 365(9459):579-87.

Kollef MH. Is there a role Antibiotic cycling in the in intensive care unit. Crit Care Med. 2001; 29(Suppl4):135-42.

Kollef MH, Micek ST. Strategies to prevent antimicrobial resistance in the intensive care unit. Crit Care Med. 2005; 33(8):1845-53.

Yates RR. Nev intervention strategies for reducing Antibiotic resistance. Chest. 1999:11513Suppl: 245-275.

Giamarellou IT, Antonizdou A. The effect of monitoring of antibiotic use on decreasing antibiotic resistance in the hospital. In: Symposium on antibiotic resistance Origins, evolution, selection and spread. Ciba Foundation Symp, London 1997. 207: 76-80.

White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997; 25(2) 230.

Özkurt Z, Erol S, Kadanalı A, Ertek M, Özdek K, Taşyaran MA. Change, is antibiotic use cost and consumption after an antibiotic restriction policy applied by infectious diseases specialists. Jpn J Infect Dis. 2005; 58(6): 338-43.

Arda B, Sipahi OR, Yamazhan T, Tasbakan M, Pullukcu H, Tunger A, Buke c, Ulusoy S. Short-term effect of antibiotic control policy on the usage patterns and cost of antimicrobials, mortality, nosocomial infection rates and antibacterial resistance. J Infect. 2007; 55(1) 41-8.

Sipahi OR. Economics of antibiotic resistance. Expert Rev Anti Infect Ther. 2008; 6(4):523-39.

Leanne B. Gasink Md, Lautenbach E, Prevention and Treatment of Health Care- Acquired İnfections. Med Clin N Am. 2008:92:295-313.

Patterson JE, Multidrug-resistant gram-negative pathogens: multiple approaches and measures for prevention. Infect Control Hosp Epidemiol. 2006;27:889-92.

Talboot GH, Bradley J, Edwards JE Jr, Gilbert D, Scheld M, Barlett JG. Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin infect Dis. 2006;42:657-68.

Heyland DK, Cook DJ, Griffith L, Keenan SP, Brun-Buisson C. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med. 1999;159:1249-56.

Loupland KB, Zygun DA, Doig CJ, et al. One year mortability of blood stream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med. 2005;31-213-19.

Barsanti MC, Woeltje KF. Infection prevention in the intensive care unit. Infect Dis Clin North. 2009; 23:703-25.

Anonim, 2019. World Health Organization, WHO Global Strategy for containment of antibiotic resistance Who/CDS/CSR/DRS/2001.2.

Ho PL, Cheng JC, Ching PT, et al. Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement. Hong Kong Med J. 2006;12-141-48.

Agalar C. Antibiyotik seçimi için ek bileşenler. Ed. Prof Dr. Dilek Arman, Prof. Dr. Oğuz Güç. Birinci Basamakta enfeksiyon Hastalıklarının Tedavisi: Akılcı Farmakoterapi, Bilimsel Tıp Yayınevi, Ankara 2008;41-9.